William R. Sellers

85.3k citations

165 papers · 34.8k indexed · 19 hit papers · h-index 82

Oncology top 0.05%
- Cancer-related Molecular Pathways 29
Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 16
Molecular Biology top 0.05%
- PI3K/AKT/mTOR signaling in cancer 29
- Melanoma and MAPK Pathways 15
- Genomics and Chromatin Dynamics 14
- Gene expression and cancer classification 12
Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research 14
Genetics top 0.5%
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 13

Co-authors: Matthew Meyerson Francisca Vázquez Heidi Greulich William G. Kaelin Pasi A. Jänne Massimo Loda Frederic J. Kaye J. Guillermo Paez
Cited by: Oncology Cancer Research Molecular Biology
Journals: Nature (5 papers)Science (1 paper)Cell (4 papers)
Partner nations: United States Switzerland Germany

In The Last Decade

William R. Sellers

157 papers receiving 34.0k citations

Hit Papers

15 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 Cell
2013 Nature
2013 Cancer Discovery
2009 Cancer Research
2008 Molecular Cancer Therapeutics
2005 Nature
2005 PLoS Medicine
2005 Nature
2004 Science
2004 Nature Medicine
2004 Journal of Clinical Oncology
2004 Cancer Cell
2003 Cancer Cell
2002 Cancer Cell
2000 Molecular and Cellular Biology
1999 PubMed
1996 Molecular and Cellular Biology
1995 Nature
1992 Cell

Peers

Countries citing papers authored by William R. Sellers

Since Specialization

Citations

This map shows the geographic impact of William R. Sellers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Sellers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Sellers more than expected).

Fields of papers citing papers by William R. Sellers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Sellers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Sellers. The network helps show where William R. Sellers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William R. Sellers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William R. Sellers Line = papers co-authored together William R. Sellers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation Clinical Cancer Research ·Sabrina Baltschukat,Barbara Schacher Engstler,Alan Huang,Huai-Xiang Hao,Angela Tam,Hui Qin Wang,Jinsheng Liang,Matthew T. DiMare,Hyo-Eun Carrie Bhang,Youzhen Wang,Pascal Furet,William R. Sellers,Francesco Hofmann,Joseph Schoepfer,Ralph Tiedt	2019	105
2	Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling Cancer Research ·Marie Schoumacher,Kristen E. Hurov,Joseph Lehár,Yan Yan‐Neale,Yuji Mishina,Dmitriy Sonkin,Joshua M. Korn,Daisy Flemming,Michael D. Jones,Brandon Antonakos,Vesselina G. Cooke,Janine Steiger,Jebediah Ledell,Mark Stump,William R. Sellers,Nika N. Danial,Wenlin Shao	2014	28
3	An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)breakdown → Cancer Discovery ·Manav Korpal,Joshua M. Korn,Xueliang Gao,Daniel P. Rakiec,David A. Ruddy,Shivang Doshi,Jing Yuan,Steve G. Kovats,Sunkyu Kim,Vesselina G. Cooke,John E. Monahan,Frank Stegmeier,Thomas M. Roberts,William R. Sellers,Wenlai Zhou,Ping Zhu	2013	425
4	The Novel Oral Hsp90 Inhibitor NVP-HSP990 Exhibits Potent and Broad-spectrum Antitumor Activities In Vitro and In Vivo Molecular Cancer Therapeutics ·Daniel L. Menezes,Pietro Taverna,Michael Rugaard Jensen,Tinya J. Abrams,Darrin D. Stuart,Guoying Karen Yu,David M. Duhl,Timothy Machajewski,William R. Sellers,Nancy Pryer,Zhenhai Gao	2012	57
5	A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients Cancer Research ·Ralph Tiedt,Elisa Degenkolbe,Pascal Furet,B.A. Appleton,Sabrina Wagner,Joseph Schoepfer,Emily Buck,David A. Ruddy,John E. Monahan,Michael D. Jones,Jutta Blank,Dorothea Haasen,Peter Drueckes,Markus Wartmann,Clive McCarthy,William R. Sellers,Francesco Hofmann	2011	99
6	An Oncogenic Role for ETV1 in Melanoma Cancer Research ·Judit Jané‐Valbuena,Hans R. Widlund,Sven Perner,Laura A. Johnson,Aurora C. Dibner,William M. Lin,Alissa C. Baker,Rosalynn M. Nazarian,Krishna G. Vijayendran,William R. Sellers,William C. Hahn,Lyn M. Duncan,Mark A. Rubin,David E. Fisher,Levi A. Garraway	2010	81
7	The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells Cancer Research ·Zainab Jagani,Dmitri Wiederschain,Alice Loo,Dan He,Rebecca Mosher,Paul Fordjour,John E. Monahan,Michael Morrissey,Yung-Mae Yao,Christoph Lengauer,Markus Warmuth,William R. Sellers,Marion Dorsch	2010	48
8	Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidneybreakdown → Cancer Research ·Rameen Beroukhim,Jean-Philippe Brunet,Arianna Di Napoli,Kirsten D. Mertz,Apryle Seeley,Maira M. Pires,David Linhart,Robert Worrell,Holger Moch,Mark A. Rubin,William R. Sellers,Matthew Meyerson,W. Marston Linehan,William G. Kaelin,Sabina Signoretti	2009	310
9	PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers Cancer Research ·Susan Wee,Zainab Jagani,Kay X. Xiang,Alice Loo,Marion Dorsch,Yung‐Mae Yao,William R. Sellers,Christoph Lengauer,Frank Stegmeier	2009	354
10	Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel Cancer Research ·Ayana Sawai,Sarat Chandarlapaty,Heidi Greulich,Mithat Gönen,Qing Ye,Carlos L. Arteaga,William R. Sellers,Neal Rosen,David B. Solit	2008	145
11	Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activitybreakdown → Molecular Cancer Therapeutics ·Sauveur-Michel Maira,Frédéric Stauffer,Josef Brueggen,Pascal Furet,Christian Schnell,Christine Fritsch,Saskia M. Brachmann,Patrick Chêne,Alain De Pover,Kevin Schoemaker,Doriano Fabbro,Daniela Gabriel,Marjo Simonen,Leon O. Murphy,Peter M. Finan,William R. Sellers,Carlos García-Echeverría	2008	954
12	A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling Cancer Research ·Alex Gaither,Dale Porter,Yao Yao,Jason Borawski,Guang Yang,Jerry Donovan,David R. Sage,Joanna Slisz,Mary Tran,Christopher Straub,Tim Ramsey,Vadim Iourgenko,Alan Huang,Yan Chen,Robert Schlegel,Mark Labow,Stephen E. Fawell,William R. Sellers,Leigh Zawel	2007	178
13	Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane Proceedings of the National Academy of Sciences ·Francisca Vázquez,Satomi Matsuoka,William R. Sellers,Toshio Yanagida,Masahiro Ueda,Peter N. Devreotes	2006	155
14	Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor Receptor Cancer Research ·James V. Alvarez,Heidi Greulich,William R. Sellers,Matthew Meyerson,David A. Frank	2006	206
15	TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer Cancer Research ·Sven Perner,Francesca Demichelis,Rameen Beroukhim,Folke Schmidt,Juan Miguel Mosquera,Sunita R. Setlur,Joëlle Tchinda,Scott A. Tomlins,Matthias D. Hofer,Kenneth J. Pienta,Rainer Kuefer,Robert L. Vessella,Xiao Sun,Matthew Meyerson,Charles Lee,William R. Sellers,Arul M. Chinnaiyan,Mark A. Rubin	2006	388
16	p63 regulates commitment to the prostate cell lineage Proceedings of the National Academy of Sciences ·Sabina Signoretti,Maira M. Pires,Meghan Lindauer,James W. Horner,Chiara Grisanzio,Sonya Dhar,Pradip K. Majumder,Frank McKeon,Philip W. Kantoff,William R. Sellers,Massimo Loda	2005	121
17	Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis Cancer Research ·Xiaojun Zhao,Barbara A. Weir,Thomas LaFramboise,Ming Gang Lin,Rameen Beroukhim,Levi A. Garraway,Javad Beheshti,Jeffrey C. Lee,Katsuhiko Naoki,William G. Richards,David J. Sugarbaker,Fei Chen,Mark A. Rubin,Pasi A. Jänne,Luc Girard,John D. Minna,David C. Christiani,Cheng Li,William R. Sellers,Matthew Meyerson	2005	242
18	EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapybreakdown → Science ·J. Guillermo Paez,Pasi A. Jänne,Jeffrey C. Lee,Sean Tracy,Heidi Greulich,Stacey Gabriel,Paula Herman,Frederic J. Kaye,Neal I. Lindeman,Titus J. Boggon,Katsuhiko Naoki,Hidefumi Sasaki,Yoshitaka Fujii,Michael J. Eck,William R. Sellers,Bruce E. Johnson,Matthew Meyerson	2004	7539
19	An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays Cancer Research ·Xiaojun Zhao,Cheng Li,J. Guillermo Paez,Koei Chin,Pasi A. Jänne,Tzu-Hsiu Chen,Luc Girard,John D. Minna,David C. Christiani,Chris Leo,Joe W. Gray,William R. Sellers,Matthew Meyerson	2004	401
20	Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells Cancer Research ·Raanan Berger,Phillip G. Febbo,Pradip K. Majumder,Jean J. Zhao,Sayan Mukherjee,Sabina Signoretti,Katrina Campbell,William R. Sellers,Thomas M. Roberts,Massimo Loda,Todd R. Golub,William C. Hahn	2004	140

About William R. Sellers

William R. Sellers is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 165 papers that have together received 34.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (29 papers), Cancer-related Molecular Pathways (29 papers), Cancer Genomics and Diagnostics (16 papers), Melanoma and MAPK Pathways (15 papers), Genomics and Chromatin Dynamics (14 papers), Prostate Cancer Treatment and Research (14 papers), Cancer Mechanisms and Therapy (13 papers) and Gene expression and cancer classification (12 papers). The work is most often cited by research in Oncology (13.6k citations), Cancer Research (7.1k citations) and Molecular Biology (22.7k citations). William R. Sellers has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Matthew Meyerson, Francisca Vázquez, Heidi Greulich, William G. Kaelin, Pasi A. Jänne, Massimo Loda, Frederic J. Kaye, J. Guillermo Paez, Jeffrey C. Lee and Noriaki Nakamura. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact